Thomas Pike - Pres & CEO Clinical Business at LABCORP HOLDINGS INC.

Issuer-level insider activity

Role
Pres & CEO Clinical Business
Issuer ticker
LH on NYSE
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Thomas Pike since 10 Sep 2025

Reported holdings for Thomas Pike in LABCORP HOLDINGS INC.

Form 4 holding Pres & CEO Clinical Business

LABORATORY CORP OF AMERICA HOLDINGS

Security class
Restricted Stock Unit
Shares / value
16,960
Estimated value
$3,573,692
Report date
09 Jan 2023
Price
$210.71
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Thomas Pike in LABCORP HOLDINGS INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .